BRPI0113247E2 - composition and method for the treatment of skin disorders in a human - Google Patents

composition and method for the treatment of skin disorders in a human

Info

Publication number
BRPI0113247E2
BRPI0113247E2 BRPI0113247A BRPI0113247E2 BR PI0113247 E2 BRPI0113247 E2 BR PI0113247E2 BR PI0113247 A BRPI0113247 A BR PI0113247A BR PI0113247 E2 BRPI0113247 E2 BR PI0113247E2
Authority
BR
Brazil
Prior art keywords
composition
human
treatment
skin disorders
preservative
Prior art date
Application number
Other languages
Portuguese (pt)
Inventor
Gordon J Dow
Robert W Lathrop
Debra A Dow
Original Assignee
Dow Pharmaceutical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Pharmaceutical Sciences filed Critical Dow Pharmaceutical Sciences
Priority to BRPI0113247 priority Critical patent/BRPI0113247E2/en
Publication of BRPI0113247E2 publication Critical patent/BRPI0113247E2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSIÇçO E METODO PARA O TRATAMENTO DE DESORDENS DA PELE EM UM SER HUMANO. É provida uma composição que possui uma viscosidade de menos do que 15.000 cP para o tratamento de uma desordem de pele num ser humano. A composição consiste essencialmente de: (a) um teor terapeuticamente eficaz furoato de mometasona, (b) um ácido policrilico levemente reticulado, farmaceutimente aceitável, compatível com o composto, (c) uma base farmaceuticamente aceitável para ajustar o pH, (d) pelo menos um solvente miscível em água, (e) opcinalmente um conservante ou uma combinação de mais do que um conservante, (f) pelo menos um tensoativo em combinação com uma fase oleosa, suficiente para formar uma loção, e (g) água. A composição de baixa viscosidade possuí a vantagem de ser administrada mais acuradamente quando combinada com um recipiente que administra a composição em gotas.COMPOSITION AND METHOD FOR TREATMENT OF SKIN DISORDERS IN A HUMAN BEING. A composition having a viscosity of less than 15,000 cP is provided for treating a skin disorder in a human. The composition essentially consists of: (a) a therapeutically effective mometasone furoate content, (b) a pharmaceutically acceptable, slightly cross-linked polycrylic acid compatible with the compound, (c) a pharmaceutically acceptable base for adjusting the pH, (d) at least at least one water-miscible solvent, (e) optionally a preservative or a combination of more than one preservative, (f) at least one surfactant in combination with an oil phase sufficient to form a lotion, and (g) water. The low viscosity composition has the advantage that it is administered more accurately when combined with a container that delivers the droplet composition.

BRPI0113247 2009-04-28 2009-04-28 composition and method for the treatment of skin disorders in a human BRPI0113247E2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0113247 BRPI0113247E2 (en) 2009-04-28 2009-04-28 composition and method for the treatment of skin disorders in a human

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0113247 BRPI0113247E2 (en) 2009-04-28 2009-04-28 composition and method for the treatment of skin disorders in a human

Publications (1)

Publication Number Publication Date
BRPI0113247E2 true BRPI0113247E2 (en) 2010-12-14

Family

ID=43332439

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0113247 BRPI0113247E2 (en) 2009-04-28 2009-04-28 composition and method for the treatment of skin disorders in a human

Country Status (1)

Country Link
BR (1) BRPI0113247E2 (en)

Similar Documents

Publication Publication Date Title
BR0113247A (en) Composition, method for the treatment of skin disorders in a human, method for the preparation of a composition
CL2017002939A1 (en) Topical pharmaceutical compositions
BR112014010275A2 (en) diabetes treatment formulations
BR112015001419A2 (en) compound, pharmaceutical composition, and methods for inhibiting romk in a patient, causing diuresis, natriuresis, or both, and for treating one or more disorders.
BRPI0822162B8 (en) pharmaceutical composition for topical treatment of nail disease or nail bed
ECSP10010589A (en) PHARMACO AGAINST LIVER CANCER
WO2012136969A3 (en) Ophthalmic treatments
MX2021000376A (en) Pain-relieving topical compositions.
EA201070940A1 (en) LIQUID DOSAGE FORM FSH
BRPI0510760A (en) method for administering to a patient a composition, topical composition, and patch
BR112015005339A8 (en) use of miracle fruit seed oil as an active ingredient
MX338746B (en) Vitamin d3 and analogs thereof for treating alopecia.
WO2009022338A3 (en) Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
EP2275104A3 (en) Pharmaceutical and cosmetic composition including lactoferrin, ciclopirox and etidronic acid
PL2033635T3 (en) Use of phenylbutyric acid or salts thereof for treating pruritus
NZ589971A (en) Emollient composition comprising glycerol, vaseline and liquid paraffin
BR112019003136A2 (en) multi-unit dosage form of pharmaceutical composition, unit dosage form of pharmaceutical composition, multi-unit / unit dosage form, kit and method of treating a condition treatable by oral administration of a therapeutically active agent
EA201291335A1 (en) PHARMACEUTICAL COMPOSITIONS FOR LOCAL APPLICATION
BR112015001627A2 (en) pharmaceutical composition, their uses and method of decreasing the frequency of urination
BR112014030288A2 (en) pharmaceutical composition
BRPI0113247E2 (en) composition and method for the treatment of skin disorders in a human
WO2015100348A8 (en) Keloid reduction using topical allantoin
RU2015145451A (en) PRODUCTS FOR LOCAL USE CONTAINING HYALURONIC ACID, VERBASCOZIDE AND GLYCEROPHOSPHOINOSITOL
BR112015018144A8 (en) stable water / pharmaceutical oil emulsion composition with gauge oil droplets, method for making the same high single dose of clopidogrel used to treat a patient
EP2514409A1 (en) Topical pharmaceutical compositions of nimesulide and methylsulfonylmethane